Bedfordshire and Luton Joint Formulary
Bedfordshire Hospitals NHS Foundation Trust
Bedfordshire, Luton and Milton Keynes ICB
netFormulary
Home
Treatment Use
Class
Chapters
News
Reports
Contact
SEARCH
Searching for :
Ravulizumab
Open monograph to display formulary status.
Formulary items found
Status
Description
Section
RED
Ravulizumab Ultomiris
®
(300 mg/3 mL/1,100 mg/11 mL/ 300 mg/30 mL concentrate for solution for infusion)
Nutrition and blood, Drugs used in hypoplastic, haemolytic, and renal anaemias and in sickle cell disease, 09.01.03
Links found
NICE TA1010: Danicopan with ravulizumab or eculizumab for treating paroxysmal nocturnal haemoglobinuria
NICE TA698: Ravulizumab for treating paroxysmal nocturnal haemoglobinuria
NICE TA710 Ravulizumab for treating atypical haemolytic uraemic syndrome
NICE TA940: Ravulizumab for treating generalised myasthenia gravis (TERMINATED APPRAISAL)
NICE TA941: Ravulizumab for treating AQP4 antibody-positive neuromyelitis optica spectrum disorder (TERMINATED APPRAISAL)